Daniel M. Junius
2012
In 2012, Daniel M. Junius earned a total compensation of $2.4M as President and Chief Executive Officer at ImmunoGen, a 39% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $235,200 |
---|---|
Option Awards | $1,657,800 |
Salary | $480,000 |
Other | $8,832 |
Total | $2,381,832 |
Junius received $1.7M in option awards, accounting for 70% of the total pay in 2012.
Junius also received $235.2K in non-equity incentive plan, $480K in salary and $8.8K in other compensation.
Rankings
In 2012, Daniel M. Junius' compensation ranked 2,967th out of 11,487 executives tracked by ExecPay. In other words, Junius earned more than 74.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,967 out of 11,487 | 74th |
Division Manufacturing | 1,040 out of 4,253 | 76th |
Major group Chemicals And Allied Products | 235 out of 1,198 | 80th |
Industry group Drugs | 138 out of 920 | 85th |
Industry Pharmaceutical Preparations | 111 out of 700 | 84th |
Source: SEC filing on September 30, 2014.
Junius' colleagues
We found four more compensation records of executives who worked with Daniel M. Junius at ImmunoGen in 2012.